Aktien aus dem Gesundheitswesen
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2007 | INVA Innoviva, Inc. - Common Stock | 21.51 USD | +9942.02% | -3.89% | -6.23% | +20.71% | 1.59 B USD | ||
| 2011 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 14.06 USD | -2.02% | +2.93% | -11.46% | +171.43% | 1.56 B USD | ||
| 2013 | VIR Vir Biotechnology, Inc. - Common Stock | 0.09 USD | -5.35% | -99.03% | -99.10% | -98.49% | 15.23 M USD | ||
| 2014 | WGS GeneDx Holdings Corp. - Class A Common Stock | 52.00 USD | +0.02% | +8.15% | -20.15% | -27.03% | 1.54 B USD | ||
| 2018 | ANAB AnaptysBio, Inc. - Common Stock | 53.14 USD | +9445.54% | -11.43% | -20.66% | +50.97% | 1.55 B USD | ||
| 2020 | AGL agilon health, inc. Common Stock | 92.44 USD | +0.11% | +4.59% | +235.41% | +4063.96% | 1.54 B USD | ||
| 2028 | GHRS GH Research PLC - Ordinary Shares | 0.25 USD | -98.96% | -98.88% | -98.79% | -98.23% | 15.40 M USD | ||
| 2029 | PGEN Precigen, Inc. - Common Stock | 4.12 USD | -5.07% | -3.96% | +1.48% | +209.77% | 1.47 B USD | ||
| 2038 | FTRE Fortrea Holdings Inc. - Common Stock | 15.75 USD | +2.34% | +17.54% | +29.20% | +267.99% | 1.49 B USD | ||
| 2044 | PRGO Perrigo Company plc Ordinary Shares | 10.70 USD | +9574.50% | -4.72% | -9.86% | -50.28% | 1.48 B USD | ||
| 2045 | IMTX Immatics N.V. - Ordinary Shares | 11.14 USD | +9578.54% | -4.62% | +3.63% | +7.63% | 1.49 B USD | ||
| 2050 | MBX MBX Biosciences, Inc. - Common Stock | 30.65 USD | -2.61% | -4.87% | +3.69% | +145.00% | 1.46 B USD | ||
| 2053 | INBX Inhibrx Biosciences, Inc. - Common Stock | 99.29 USD | -4.54% | -6.19% | -22.42% | +23.22% | 1.46 B USD | ||
| 2055 | AVAH Aveanna Healthcare Holdings Inc. - Common Stock | 6.67 USD | -6.97% | -9.50% | +1.68% | +24.67% | 1.45 B USD | ||
| 2065 | ARDX Ardelyx, Inc. - Common Stock | 5.73 USD | -5.13% | -6.83% | -19.75% | +53.62% | 1.42 B USD | ||
| 2072 | AVBP ArriVent BioPharma, Inc. - Common Stock | 30.69 USD | +1.39% | +13.41% | +2.64% | +42.68% | 1.43 B USD | ||
| 2073 | IMCR Immunocore Holdings plc - American Depositary Shares | 0.29 USD | +0.83% | -99.00% | -98.97% | -99.13% | 14.82 M USD | ||
| 2074 | TDOC Teladoc Health, Inc. Common Stock | 7.91 USD | +10294.22% | +20.03% | +21.88% | -18.62% | 1.43 B USD | ||
| 2089 | ATRC AtriCure, Inc. - Common Stock | 26.48 USD | -4.30% | -6.07% | -7.77% | -30.19% | 1.34 B USD | ||
| 2093 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 18.82 USD | -1.88% | +3.46% | +12.69% | +96.86% | 1.39 B USD |
Nachrichten Aktien aus dem Gesundheitswesen
Cytokinetics: Direktor Edward Kaye verkauft Aktien im Wert von 223.171 US-Dollar
Cytokinetics: Direktorin Parshall veräußert Aktien im Wert von 370.400 $
Protagonist Therapeutics: Direktor Waddill verkauft Aktien im Wert von 896.760 US-Dollar
HealthEquity-Direktorin veräußert Aktienpaket im Wert von 219.510 US-Dollar
Illumina-Direktor Keith Meister veräußert Aktien im Wert von 107 Millionen US-Dollar
HealthEquity: Top-Manager verkauft Aktien im Wert von 675.000 US-Dollar
Insider-Verkauf bei Si-Bone: Director Davis Jr. veräußert Aktien im Wert von 104.000 $
Gainers Aktien aus dem Gesundheitswesen
EWTX Edgewise Therapeutics, Inc. - Common Stock | 40.26 | +11685.71% |
MBIO Mustang Bio, Inc. - Common Stock | 0.77 | +11392.54% |
PMI Picard Medical, Inc. Common Stock | 0.17 | +11233.33% |
HYPD Hyperion DeFi, Inc. - Common Stock | 3.86 | +10928.57% |
CLYM Climb Bio, Inc. - Common Stock | 11.80 | +10666.42% |
ADGM Adagio Medical Holdings, Inc - Common Stock | 0.77 | +10594.44% |
ORIC Oric Pharmaceuticals, Inc. - Common Stock | 8.98 | +10527.22% |
PIII P3 Health Partners Inc. - Class A Common Stock | 12.91 | +10499.34% |